Avet Lifesciences Private Limited, a active private limited company, was established on 26 August 2020 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299PN2020PTC193397. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹15.45 Cr.
Formerly known as Avet Lifesciences Limited. Employing 28 professional, Its leadership includes Ulhas Rajaram Puranik (Director), Brijmohan Sharma (Director). Past directors included Shreekant Krushnaji Bapat, Saurabh Mathur, Ulhas Rajaram Puranik. It holds ₹250.00 Cr open charges and ₹1,308.40 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-402, 4Th Floor, Ganga Osian Square, Survey No. 249/250, Tal – Mulshi, Wakad, Pune, Maharashtra, 411057.
U24299PN2020PTC193397
193397
26 August 2020
₹20.00 Cr
₹15.45 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Avet Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ulhas Rajaram Puranik | Director | 22 Sep 2021 | Current |
| Brijmohan Sharma | Director | 06 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Sep 2021 | Past |
| Pramod Abcsdd | Director | 06 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Director | 23 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avet Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.44% increase. The company also saw a substantial fall in profitability, with a 129.13% decrease in profit. The company's net worth dipped by a decrease of 1.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Avet Lifesciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000,000.00
₹13,084,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2025 | Others | ₹83.40 Cr | Open |
| 19 Mar 2025 | Others | ₹166.60 Cr | Open |
| 05 Sep 2024 | Citi Bank N.A. | ₹83.40 Cr | Satisfied |
| 14 Jun 2024 | Citi Bank N.A. | ₹83.40 Cr | Satisfied |
| 14 Jun 2024 | Citi Bank N.A. | ₹166.60 Cr | Satisfied |
Explore comprehensive loan charge details -
Avet Lifesciences has a workforce of 28 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Avet Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avet Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 05 Sep 2024 via Charge ID 100974526 with Citi Bank N.A. was fully satisfied on 04 Apr 2025. was documented.
The activity A charge registered on 14 Jun 2024 via Charge ID 100944639 with Citi Bank N.A. was fully satisfied on 04 Apr 2025. was completed.
A charge registered on 14 Jun 2024 via Charge ID 100944392 with Citi Bank N.A. was fully satisfied on 04 Apr 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 83.40 Cr with Charge ID 101076744 was registered on 19 Mar 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 166.60 Cr with Charge ID 101076734 was registered on 19 Mar 2025. was completed.
The activity Neha Mayur Ruparel was appointed as a Company Secretary was appointed as a Company Secretary on 23 Dec 2024 & has been associated with this company since 11 months 8 days . was completed.
The CIN of Avet Lifesciences Private Limited is U24299PN2020PTC193397.
Avet Lifesciences Private Limited is headquartered at A-402, 4Th Floor, Ganga Osian Square, Survey No. 249/250, Tal – Mulshi, Wakad, Pune, Maharashtra, 411057.
Avet Lifesciences Private Limited was incorporated on 26 August 2020.
The current directors of Avet Lifesciences Private Limited are
The primary industry of Avet Lifesciences Private Limited is Manufacturing.
Avet Lifesciences Private Limited is unlisted.
The authorized capital of Avet Lifesciences Private Limited is ₹20.00 Cr, and the paid-up capital is ₹15.45 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX